Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia

Haematologica

Volumn 99, Issue 10, 2014, Pages e199-e200

  Talbot, Alexis ^a   de Latour, Régis Peffault ^a   Raffoux, Emmanuel ^a   Buchbinder, Nimrod ^b   Vigouroux, Stéphane ^c   Milpied, Noel ^c   Leblanc, Thierry ^d   Soulier, Jean ^a   Michallet, Mauricette ^e   Socié, Gérard ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

AML; Fanconi anemia; Sequential chemotherapy; Transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; STEROID; THYMOCYTE ANTIBODY; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTEREMIA; CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLONAL EVOLUTION; DIARRHEA; FANCONI ANEMIA; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; LOW DRUG DOSE; MALE; MAXILLA SINUSITIS; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; TREATMENT OUTCOME; YOUNG ADULT; ALLOTRANSPLANTATION; COMPLICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA, MYELOID, ACUTE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FANCONI ANEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84907554392     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.098954     Document Type: Letter

References (7)

1. MacMillan ML, Wagner JE. Haematopoeitic cell transplantation for Fanconi anaemia -when and how? Br J Haematol. 2011;149(1):14-21.
2. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101(3):822-6.
3. Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105(1):67-73.
4. Alter BP, Greene MH, Velazquez I, Rosenberg PS. Cancer in Fanconi anemia. Blood. 2003;101(5):2072.
5. Guardiola P, Kurre P, Vlad A, Cayuela JM, Esperou H, Devergie A, et al. Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia. Br J Haematol. 2003;122(5):806-9.
6. Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005;23(24):5675-87.
7. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945-56.